Tag: Nasdaq:TCRX

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

December 26, 2024 07:00 ET  | Source: TScan Therapeutics, Inc. WALTHAM, Mass.,…

GlobeNews Wire GlobeNews Wire
undefined